Herbalife: Profiting From The Obesity Pandemic

Summary

• As the wrath of notable activist investors is abated, Herbalife settled with the FTC and seemingly moved on.
• Earnings increase is expected in the foreseeable future due to brand enhancement and the absence of costly legal fees.
• By capturing the obesity pandemic, Herbalife has much room for further growth.
• Valuations suggest the company is a significant bargain.

Since 2012, companies operating in the personal wellness industry - Nu Skin Enterprises (NYSE:NUS) and USANA Health Sciences (NYSE:USNA) - experienced tumultuous tanking in share price, as notorious activist investors waged their battles. Slugging in the red corner is the famed bear, Bill Ackman (principal of Pershing Square). Charging in the green corner is the golden bull, Carl Icahn, of Icahn Enterprises (NYSE:IEP). With their history of personal and professional conflicts, these two titans slugged it out in the epic battles for Herbalife Ltd. (NYSE:HLF). Headquartered in the Cayman Islands, the company makes "nutrition products with protein, fiber, and vitamins to enhance and support a healthy and balanced lifestyle."

To learn more how Dr. Tran BioSci can serve your specific needs ...

If you enjoy reading our research, be sure to sign up for our mailing list at Dr. Tran BioSci to get the latest market outperforming insights.

To access the complete article, please go to the premier investing research platform Seeking Alpha.

Nu Skin Enterprises: A Peter Lynch Stalwart With Uber Upsides

Summary

• As a leading wellness products seller with more than $2B in revenues, Nu Skin is generating attractive earnings, paying increasing dividends, and executing prudent share repurchases.
• Continued growth is expected due to its strong business moat in Asia.
• After tumbling from its peak share price in 2014, the stock is gaining momentum for past two years; yet valuation indicates it is undervalued with 19% upsides.

In 2012, Andrew Left (a notorious short seller with arguably unmatched accuracy) alleged that Nu Skin Enterprises (NYSE: NUS) - a firm that directly sells wellness products - was operating an illegal multi-level marketing ("MLM") business in China. Despite that shocking news, share price continues to levitate to its peak in H2 2013.

To learn more how Dr. Tran BioSci can serve your specific needs ...

If you enjoy reading our research, be sure to sign up for our mailing list at Dr. Tran BioSci to get the latest market outperforming insights.

To access the complete article, please go to the premier investing research platform Seeking Alpha.